Grace Therapeutics, Inc. (GRCE)

SEC filing

Grace Therapeutics, Inc.

GRCE · CIK 1444192

4 · Oct 5, 2026 · 10% Owner Opaleye Management Inc. bought 60.49K Common Stock, par value $0.0001 per share at $2.05/unit ($123.8K)

10% Owner Opaleye Management Inc. bought 60.49K Common Stock, par value $0.0001 per share at $2.05/unit ($123.8K)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).